KYTX: Kyverna Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati

Kyverna Therapeutics (KYTX) tovar belgisi

Ishlab chiqarish va sinovlarni uchinchi tomon pudratchilariga topshirish orqali Kyverna Therapeutics (KYTX) chaqqonlikni saqlab qolmoqda, bu esa bioinformatiklarining agressiv ravishda ishga qabul qilinishi va tadqiqot va ishlanmalar (R&D) xodimlarini ushlab qolish uchun aksiyalar opsiyonlaridan foydalanish bilan yanada kuchaytirilgan. PEG koeffitsiyenti ushbu strategiyaning natijasini vizuallashtiradi, bunda 0.00 darajasi joriy bozor bahosini aks ettiradi. Bunday yondashuv autoimmun patologiyalarga qarshi kurashish uchun inqilobiy CAR-T terapiyalarini ishlab chiqayotgan istiqbolli brendning maqomini mustahkamlaydi.

KYTX Kyverna: Narxning foydaga va o‘sish sur’atiga nisbati 21.02.2024 - 16.11.2026 oraligʻida

Kyverna (KYTX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:KYTX - Kyverna Therapeutics, Inc
Kyverna Therapeutics Inc. brend mahsuloti

Yuqori o'sishga ega aktivlarni tanlashda xatarlarni minimallashtirish uchun bozor baholashining biznes kengayish sur'atlari bilan uyg'unligini baholash zarur. Ushbu metrika, P/E ko'rsatkichining aksiyaga to'g'ri keladigan foydaning yillik o'sish sur'atiga nisbati sifatida hisoblanadi va narx-foyda nisbatining EPS o'sishiga nisbati 1 dan past bo'lganda aktivning past baholanganligini aniqlash imkonini beradi, bu ko'rsatkich Kyverna Therapeutics (KYTX) uchun hozirda 0.00 ni tashkil etib, noyob CAR-T terapiyasi va tizimli qizil bog'lanma to'qimasi (lupus) davolashiga bo'lgan elastik bo'lmagan talab tufayli kapitalizatsiya salohiyatini tasdiqlaydi.

Kyverna Therapeutics raqobatchilari

ARGX (Argenx) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (biontech.de)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax S.A. (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|Protagonist Therapeutics, Inc. (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant Therapeutics (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori adaptivebiotech.com|Narxning foydaga va o‘sish sur’atiga nisbati Celldex (CLDX)|Aurinia Pharmaceuticals Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (biocryst.com)|Vera Therapeutics, Inc. (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Therapeutics, Inc. - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tourmaline Corp (TRML)|PGEN (precigen.com) - PEG multiplikatori|PEG multiplikatori Pharming Corp|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Bio Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Bio ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharmaceuticals KALV|Septerna (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|pieris.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|ATXS (Astria Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Holdings Inc. ENGN|PEG multiplikatori RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Aclaris Therapeutics Inc.|TLSA: PEG multiplikatori|CABA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|VTYX (ventyxbio.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Theratechnologies Inc. THTX|Narx-foyda va o‘sish multiplikatori AVTX (avalotx.com)|Narx-foyda va o‘sish multiplikatori Eledon Pharmaceuticals, Inc. ELDN|Narxning foydaga va o‘sish sur’atiga nisbati Agenus, Inc AGEN|Climb Bio Inc - Narxning foydaga va o‘sish sur’atiga nisbati|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aTyr Pharma, Inc. ATYR|ADAG: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati IMA (ImageneBio)|Narx-foyda va o‘sish multiplikatori STTK|EQ: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Connect Pharma (CNTB)|PEG multiplikatori Immunic Therapeutics (IMUX)|PEG multiplikatori ATRA (Atara Biotherapeutics)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IFRX|XFOR (X4 Pharma) - O‘sish sur’atiga tuzatilgan narx-foyda|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACET (adicetbio.com)|CELU: PEG multiplikatori|inmunebio.com (INMB) - PEG multiplikatori|BRNS (Barinthus Biotherapeutics PLC) - PEG multiplikatori|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Narx-foyda va o‘sish multiplikatori|geovax.com - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (Edesa Biotech Inc)|IBIO: PEG multiplikatori|Carisma Tx (CARM) - PEG multiplikatori|XTLB (XTL Biopharmaceuticals) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics, Inc.)|PEG multiplikatori Aptevo (APVO)|PEG multiplikatori AIM (aimimmuno.com)|PEG multiplikatori Aditxt Corp ADTX|GRI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Revelation Bio (REVB) - PEG multiplikatori|INDP (Indaptus Corp) - PEG multiplikatori|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|Narx-foyda va o‘sish multiplikatori Affimed N.V. AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics ITOS|Ocean Biomedical (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|tcbiopharm.com (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio Inc.) - PEG multiplikatori